Latest Articles

Publication Date
GSK’s Cancer Drug Jemperli Nears EU Marketing Expansion - MSN

GSK’s Cancer Drug Jemperli Nears EU Marketing Expansion MSN

Published: Dec. 19, 2024, 1:50 p.m.
Increased risk of subsequent antiphospholipid syndrome in patients with endometriosis.

Although autoimmune abnormalities are common in patients with endometriosis, it is unknown whether patients with endometriosis have a higher risk of developing antiphospholipid syndrome (APS).

Published: Dec. 19, 2024, midnight
The effect of lysophosphatidic acid on myometrial contractility and the mRNA transcription of its receptors in the myometrium at different stages of endometrosis in mares.

Endometrosis (chronic degenerative endometritis) results in morphological changes in the equine endometrium and impairs its secretory function. However, the effect of this condition on the myometrium remains unclear. Lysophosphatidic acid …

Published: Dec. 19, 2024, midnight
Müllerian anomalies and endometriosis: associations and phenotypic variations.

Müllerian anomalies are congenital conditions characterized by the incomplete development of the female reproductive tract. Women affected by Müllerian anomalies often display additional malformations of the renal, skeletal, and cardiovascular …

Published: Dec. 19, 2024, midnight
The correlation between immune cells and endometriosis: a bidirectional two-sample mendelian randomization study.

Endometriosis (EM), a prevalent estrogen-dependent inflammatory disorder affecting women of reproductive age, is characterized by the presence of endometrial-like tissue outside the uterus, resulting in pelvic scarring, pain, and infertility. …

Published: Dec. 19, 2024, midnight
Peritoneal fluid microbiota profile of patients with deep endometriosis.

Endometriosis is a chronic gynecological disease that affects 10% of reproductive-aged women and characterized by the presence of endometrial tissue outside the uterus. The disease is linked to a pro-inflammatory …

Published: Dec. 19, 2024, midnight
Editorial: Participant characteristics and biological markers for endometriosis diagnosis or prediction of treatment response.

Published: Dec. 19, 2024, midnight
Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without RT for Newly Diagnosed, High-Risk Endometrial Cancer: Results in DMMR Tumors - Medpage Today

Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without RT for Newly Diagnosed, High-Risk Endometrial Cancer: Results in DMMR Tumors Medpage Today

Published: Dec. 18, 2024, 8:16 p.m.
Brian Slomovitz on Adjuvant Pembrolizumab/Chemotherapy for Advanced Endometrial Cancer - Medpage Today

Brian Slomovitz on Adjuvant Pembrolizumab/Chemotherapy for Advanced Endometrial Cancer Medpage Today

Published: Dec. 18, 2024, 3:27 p.m.
WellTheory Launches Program Targeting Link Between Autoimmune Disease and Hormonal Health - Femtech Insider

WellTheory Launches Program Targeting Link Between Autoimmune Disease and Hormonal Health Femtech Insider

Published: Dec. 18, 2024, 1:03 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!